Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- SCIENTIFIC REPORTS10(1) · 2020
- 피인용
- Web of Science 26Scopus 27
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 3.998
- ISSN
- 2045-2322
저자
- Warner, Richard B.제1저자Department of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA
- Najy, Abdo J.Department of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA
- 정영석Department of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA
- Fridman, RafaelDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA
- Kim, SeonghoDepartment of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA
- Kim, Hyeong-Reh Choi교신저자Department of Pathology, Wayne State University School of Medicine, Detroit, MI, 48201, USA
초록
Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a pleiotropic protein, promoting both tumor-suppressive and tumor-promoting activities. While TIMP-1 is primarily known as an endogenous inhibitor of matrix metalloproteinases (MMPs) and thus associated with tumor cell invasion, clinical studies demonstrated increased expression of TIMP-1 and its association with poor prognosis in cancer. Non-MMP-inhibitory and oncogenic functions of TIMP-1 are mediated by induction of intracellular signaling via its cell surface receptor CD63, a tetraspanin. The present study investigates the structure-function relationship of TIMP-1 for its interaction with CD63, which may eventually help design a novel approach for targeting TIMP-1's pro-oncogenic activity without interfering its tumor suppressive MMP-inhibitory function. Importantly, our analysis includes TIMP-1/CD63 interactions at the cell surface of live cells. Here, we demonstrate that the 9 C-terminal amino acid residues of TIMP-1 and the large extracellular loop of CD63 are required for their interaction. Considering that the N-terminal half of TIMP-1 is sufficient for TIMP-1's MMP-inhibitory activity, we propose that those C-terminal amino acid residues are a potentially targetable motif of TIMP-1 oncogenic activity. As a proof of concept, we present the potential for the development of neutralizing antibodies against the C-terminal motif of TIMP-1 for disruption of TIMP-1 interaction with CD63 and the subsequent signal transduction.
키워드
식별자
- Scopus EID
- 2-s2.0-85079084076
- WoS UID
- 000562828300016



로그인
연구물 목록으로